BAUDETTE, Minn., April 28, 2015 /PRNewswire/ -- ANI
Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the
Company plans to release its first quarter 2015 financial results
on Tuesday, May 5, 2015, before the
opening of the U.S. financial markets. The earnings press release
will be accessible through the Investor Relations section of the
Company's website, www.anipharmaceuticals.com.
Arthur S. Przybyl, President and
Chief Executive Officer, and Charlotte C.
Arnold, Vice President and Chief Financial Officer, also
plan to host a conference call to review those results starting at
10:30am, Eastern Time on Tuesday, May 5, 2015. The call will be open to
the public and can be accessed through a conference line by dialing
(855) 582-8078. The conference ID is 35286098.
A recording of the conference call will be available within two
hours of the completion of the call and will remain accessible for
a period of seven days following the call. To access the replay,
dial (855) 859-2056. The access code for the replay is
35286098.
About ANI
ANI Pharmaceuticals, Inc. (the "Company" or "ANI") is an
integrated specialty pharmaceutical company developing,
manufacturing, and marketing branded and generic prescription
pharmaceuticals. The Company's targeted areas of product
development currently include narcotics, oncolytics (anti-cancers),
hormones and steroids, and complex formulations involving extended
release and combination products. For more information, please
visit our website www.anipharmaceuticals.com.
For more information about ANI, please contact:
Investor Relations
(218) 634-3608
IR@anipharmaceuticals.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/ani-pharmaceuticals-schedules-conference-call-for-first-quarter-2015-financial-results-300072621.html
SOURCE ANI Pharmaceuticals, Inc.